LMR Partners’s Corbus Pharmaceuticals CRBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$242K Hold
35,500
– – ﹤0.01% 1344
2026
Q2
$333K Buy
+35,500
New +$336K ﹤0.01% 1247
2021
Q3
– Sell
-974
Closed -$53K – 1029
2021
Q2
$53K Buy
+974
New +$54.1K ﹤0.01% 982

Other funds holding CRBP

LMR Partners's CRBP Position: Q3 2026 in Review

LMR Partners held its Corbus Pharmaceuticals (CRBP) position steady in Q3 2026 at 35,500 shares worth $242K. The position accounts for ﹤0.01% of the portfolio, ranked #1344.

LMR Partners first reported a position in CRBP in Q2 2021 and has held it in 3 quarters since. The position peaked at $333K in Q2 2026. 120 funds tracked by Wall St. Rank hold CRBP as of Q3 2026.

  • LMR Partners held 35,500 shares of Corbus Pharmaceuticals worth $242K as of Q3 2026.
  • LMR Partners left its Corbus Pharmaceuticals share count unchanged in Q3 2026.
  • Corbus Pharmaceuticals made up ﹤0.01% of LMR Partners's portfolio in Q3 2026, its #1344 holding.
  • LMR Partners first reported a position in Corbus Pharmaceuticals in Q2 2021 and has held it in 3 quarters since.
  • LMR Partners's Corbus Pharmaceuticals position peaked at $333K in Q2 2026.
  • 120 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q3 2026.

Based on LMR Partners's 13F filing for Q3 2026, filed 16 Nov 2026.